← back to search

Ryan K. Muir

University of California, San Francisco · US
Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Epigenetics and DNA Methylation, HIV/AIDS drug development and treatment, Ubiquitin and proteasome pathways, and Cancer Mechanisms and Therapy.
h-index
10
citations
456
works
23
NIH funding
primary concept
email

Recent publications

Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
ACS Infectious Diseases 2021cited by 102position: middledoi
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
Journal of Nuclear Medicine 2020cited by 55position: middledoi
Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 12position: middledoi
Oscillatory cAMP signaling rapidly alters H3K4 methylation
Life Science Alliance 2019cited by 9position: middledoi
cAMP signaling regulates DNA hydroxymethylation by augmenting the intracellular labile ferrous iron pool
eLife 2017cited by 40position: middledoi
Determination of ubiquitin fitness landscapes under different chemical stresses in a classroom setting
eLife 2016cited by 95position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adam R. Renslo · University of California, San Francisco3 papers (2017–2020)Paula V. Monje · University of Kentucky2 papers (2017–2019)Ouma Onguka · Revolution Medicines (United States)2 papers (2020–2021) · 2 papers (2020–2021)Tyler C. Huff · Pfizer (United States)2 papers (2017–2019)Mirko Cortese · University of Campania "Luigi Vanvitelli"2 papers (2020–2021)Christopher J. Chang · Princeton University2 papers (2017–2019) · 2 papers (2020–2021)David Sant · Philadelphia College of Osteopathic Medicine2 papers (2017–2019)Heeyoung Kim · Heidelberg University2 papers (2020–2021)Gaofeng Wang · University of Miami2 papers (2017–2019)John M. Bennett · University of Rochester2 papers (2020–2021)Ralf Bartenschlager · German Cancer Research Center2 papers (2020–2021)Allegra T. Aron · University of Denver2 papers (2017–2019)Matthew Bogyo · Palo Alto University2 papers (2020–2021)Brett M. Babin · California Institute of Technology2 papers (2020–2021)S. Lovell · University of Kansas2 papers (2020–2021)John C. Widen · University of Minnesota, Twin Cities2 papers (2020–2021)Vladimir Camarena · University of Miami2 papers (2017–2019)Berati Cerikan · University Hospital Heidelberg2 papers (2020–2021)